Low-dose naltrexone is one of those treatments that inspires near-religious fervor in its advocates and reflexive dismissal from conventional medicine. The truth, as usual, is somewhere in the middle. LDN is a repurposed drug -- naltrexone at standard doses (50mg) is an opioid antagonist used for addiction. At very low doses (1-5mg), it appears to do something completely different: modulate the immune system, reduce inflammation, and possibly improve gut motility. The SIBO and IBS communities have embraced it as a treatment adjunct, and a growing number of integrative and functional medicine practitioners prescribe it. But does it actually help? This guide covers what the evidence says, how the dosing works, and where LDN fits (or doesn't) in a SIBO protocol.
How LDN Works (The Proposed Mechanism)
At standard doses (50mg), naltrexone blocks opioid receptors continuously, preventing the effects of opioid drugs. At low doses (1-5mg), naltrexone blocks opioid receptors only briefly -- for a few hours. This transient blockade triggers a rebound upregulation of endorphin production and opioid receptor sensitivity. The net effect, according to the theory, is increased endorphin and enkephalin levels during the remaining 20+ hours of the day. Endorphins are not just 'feel-good' chemicals -- they modulate immune function, reduce inflammation, and influence gut motility through the enteric nervous system. Specifically, LDN is proposed to reduce pro-inflammatory cytokines (TNF-alpha, IL-6), upregulate anti-inflammatory pathways, and restore immune balance in conditions characterized by chronic inflammation.
Additionally, naltrexone interacts with Toll-like receptor 4 (TLR4) on microglia and immune cells, which is involved in neuroinflammation and chronic pain signaling. By antagonizing TLR4, LDN may reduce the visceral hypersensitivity that makes SIBO and IBS symptoms feel worse than the objective pathology might suggest. This dual mechanism -- endorphin rebound plus TLR4 antagonism -- is the theoretical framework for why LDN helps inflammatory and pain conditions at doses that seem paradoxically low.
What the Evidence Actually Shows
The strongest evidence for LDN in GI conditions comes from inflammatory bowel disease. A 2013 randomized controlled trial in Gastroenterology found that LDN (4.5mg nightly) produced clinical remission in 33% of Crohn's disease patients versus 8% on placebo -- a significant difference. Endoscopic improvement was also noted. For IBS specifically, a 2023 pilot study found that LDN significantly reduced abdominal pain and improved overall IBS symptoms compared to placebo in a small cohort. For SIBO specifically, there are no published RCTs. The evidence is clinical experience and case reports from practitioners who use LDN as part of broader SIBO protocols. Many report improvements in pain, bloating, and overall well-being, but it's impossible to separate LDN's effect from the other interventions being used concurrently.
The honest assessment: LDN has plausible mechanisms, promising small studies for IBD and IBS, no direct SIBO evidence, an excellent safety profile, and low cost. It's not a primary SIBO treatment -- it won't clear bacterial overgrowth. But as an adjunct that reduces gut inflammation, may improve motility, and alleviates pain and visceral hypersensitivity, it fits rationally into a comprehensive protocol. It's one of those treatments where the risk-benefit ratio is favorable enough that many practitioners are comfortable prescribing it based on mechanistic reasoning and cross-condition evidence, even without SIBO-specific RCTs.
Dosing Protocol
LDN is typically started low and titrated up. The standard approach is to start at 0.5mg or 1mg at bedtime and increase by 0.5mg every 1-2 weeks until reaching the target dose, usually 3-4.5mg. Bedtime dosing is standard because the transient opioid blockade (and subsequent rebound) aligns with the natural endorphin peak that occurs during sleep. Some practitioners prefer morning dosing for patients who experience vivid dreams or sleep disruption at night -- both timing approaches appear to work. The target dose for most adults is 4.5mg nightly, though some patients do best at 3mg or even lower.
LDN requires a compounding pharmacy because the standard naltrexone tablet (50mg) is far too high. Compounding pharmacies prepare LDN as capsules in specific doses (0.5mg, 1mg, 1.5mg, 2mg, 3mg, 4.5mg) or as a liquid for more flexible dosing. Cost is typically $30-60 per month from a compounding pharmacy. A prescription is required. Most insurance plans don't cover compounded LDN, but the out-of-pocket cost is low enough that this rarely matters.
| Week | Dose | Notes |
|---|---|---|
| Week 1-2 | 0.5-1mg at bedtime | Starting dose, assess tolerability |
| Week 3-4 | 1.5-2mg at bedtime | Increase if no side effects |
| Week 5-6 | 2.5-3mg at bedtime | Most patients notice effects here |
| Week 7-8 | 3.5-4.5mg at bedtime | Target dose for most adults |
| Ongoing | 3-4.5mg at bedtime | Maintain; some patients do best at 3mg |
Side Effects
LDN is remarkably well-tolerated. The most common side effects are vivid dreams (sometimes enjoyable, sometimes disturbing) in the first few weeks, mild headache during titration, and occasionally nausea or mild insomnia. These typically resolve within 1-2 weeks of reaching a stable dose. If vivid dreams are bothersome, switching to morning dosing usually helps. If nausea is the issue, a slower titration (increase by 0.5mg every 2-3 weeks instead of every 1-2 weeks) is usually sufficient. Serious side effects are extremely rare at these doses. However, LDN should not be taken by anyone currently on opioid medications (including tramadol, codeine, oxycodone, and morphine) because it will precipitate acute opioid withdrawal -- this is a hard contraindication.
â ī¸Do not take LDN if you are currently taking any opioid medication, including tramadol, codeine, oxycodone, hydrocodone, morphine, methadone, or buprenorphine. LDN will precipitate opioid withdrawal, which can be severe. Also avoid LDN if you are scheduled for surgery requiring opioid anesthesia -- stop LDN at least 72 hours before.
Where LDN Fits in a SIBO Protocol
LDN is not a standalone SIBO treatment. It does not kill bacteria. It's best understood as a protocol enhancer that addresses the inflammatory and immune components of SIBO while other treatments address the bacterial overgrowth directly. The most common use cases in SIBO are: (1) as a long-term immune modulator for patients with autoimmune drivers of SIBO (Hashimoto's, Crohn's, post-infectious autoimmunity), (2) as an adjunct for patients with significant visceral hypersensitivity and pain disproportionate to breath test results, (3) as a complement to prokinetics for patients with motility dysfunction, and (4) as part of relapse prevention in patients with chronic inflammatory gut conditions.
Some practitioners start LDN during antimicrobial treatment; others prefer to start it after the active kill phase, during the maintenance and relapse prevention phase. There's no consensus. Because LDN takes 4-8 weeks to reach full effect, starting earlier means it's fully active by the time you transition to maintenance. The drug interactions are minimal -- LDN doesn't interfere with herbal or pharmaceutical antimicrobials, prokinetics, or the vast majority of supplements. The main interaction to avoid is with opioid medications.
LDN for Specific SIBO Subtypes
The immune-modulating properties of LDN may be particularly relevant for patients with post-infectious SIBO (positive anti-vinculin/anti-CdtB antibodies), where autoimmune damage to the enteric nervous system is driving motility dysfunction. By modulating immune function, LDN could theoretically help slow the autoimmune process -- though this is speculative and no studies have tested it directly. For methane-dominant SIBO (IMO), some practitioners report that LDN improves constipation -- possibly through enhanced endorphin-mediated motility signaling or through reduced intestinal inflammation. For hydrogen sulfide SIBO, LDN's anti-inflammatory effects may help with the systemic symptoms (fatigue, brain fog, muscle pain) that H2S SIBO patients often experience.
Finding a Prescriber and Compounding Pharmacy
Not all doctors are familiar with LDN, and some are hostile to the idea of repurposing a drug 'off-label' despite the practice being extremely common in medicine generally. Integrative medicine, functional medicine, and naturopathic physicians are most likely to be comfortable prescribing it. The LDN Research Trust (ldnresearchtrust.org) maintains a directory of LDN-prescribing practitioners and a list of compounding pharmacies that prepare LDN. For compounding, Skip's Pharmacy and Belmar Pharmacy are two commonly used options in the US. Most compounding pharmacies can ship nationwide with a valid prescription.
Does LDN help SIBO?
LDN doesn't treat SIBO directly -- it won't kill bacteria or clear an overgrowth. What it does is modulate the immune system, reduce gut inflammation, and may improve motility -- all of which support SIBO treatment and help prevent relapse. The strongest evidence comes from Crohn's disease and IBS studies, not SIBO specifically. Clinical experience from practitioners who use LDN as part of SIBO protocols is generally positive, particularly for patients with autoimmune drivers, significant pain, or visceral hypersensitivity. Given its excellent safety profile and low cost ($30-60/month), the risk-benefit ratio is favorable even without SIBO-specific RCTs.
What is the correct LDN dose for SIBO?
Start at 0.5-1mg at bedtime and increase by 0.5mg every 1-2 weeks until reaching the target dose, usually 3-4.5mg nightly. Some patients do best at 3mg and don't need to go higher. The slow titration is important because starting at the full dose can cause more vivid dreams, headaches, and sleep disruption. LDN requires a compounding pharmacy since standard naltrexone tablets (50mg) are far too high. Most patients reach therapeutic effect within 4-8 weeks of reaching their target dose. If vivid dreams are bothersome, switching to morning dosing is a reasonable alternative.
What are the side effects of LDN?
LDN is remarkably well-tolerated. Common side effects include vivid dreams (first 1-2 weeks), mild headache during titration, occasional nausea, and rarely mild insomnia. These typically resolve on their own. Serious side effects are extremely rare at these doses. The critical contraindication is opioid use -- do not take LDN if you're on any opioid medication (tramadol, codeine, oxycodone, morphine, etc.) because it will precipitate acute withdrawal. Also stop LDN at least 72 hours before surgery requiring opioid anesthesia. Beyond that, drug interactions are minimal -- LDN doesn't interfere with most GI medications, antimicrobials, prokinetics, or supplements.
How long does it take for LDN to work?
Most patients begin noticing effects -- improved energy, reduced pain, better overall well-being -- within 2-4 weeks of reaching their target dose. Full therapeutic effect typically takes 4-8 weeks. Because of the slow titration needed (starting at 0.5-1mg and working up to 3-4.5mg over 6-8 weeks), the total time from first dose to full effect can be 8-12 weeks. Some patients notice improvements during the titration phase; others don't notice anything until they've been at the target dose for several weeks. Give LDN at least 3 months at the target dose before deciding it doesn't work for you.
Can I take LDN with my SIBO medications?
Yes, with one critical exception: do not combine LDN with any opioid medication. Beyond that, LDN is compatible with rifaximin, herbal antimicrobials, prokinetics (prucalopride, erythromycin, ginger), PPIs, antihistamines, mast cell stabilizers, and the vast majority of supplements. There are no known interactions with herbal antimicrobials like berberine, oregano oil, or allicin. The only timing consideration is that LDN is typically taken at bedtime and doesn't need to be separated from other medications by any specific interval. Some practitioners start LDN during antimicrobial treatment; others wait until the maintenance phase. Both approaches are reasonable.
âšī¸Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. LDN is a prescription medication that requires a healthcare provider's supervision. It has a critical contraindication with opioid medications. Always work with a qualified practitioner before starting LDN.